Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
146.6 USD | +0.32% | -1.82% | -6.59% |
04:34pm | J&J: positive CHMP opinion for lung cancer | CF |
01:38pm | Addex Therapeutics Shares Plunge Premarket on Epilepsy Study Failure | DJ |
Financials (USD)
Sales 2024 * | 88.39B | Sales 2025 * | 90.87B | Capitalization | 352B |
---|---|---|---|---|---|
Net income 2024 * | 22.02B | Net income 2025 * | 22.97B | EV / Sales 2024 * | 3.9 x |
Net cash position 2024 * | 7B | Net cash position 2025 * | 21.07B | EV / Sales 2025 * | 3.64 x |
P/E ratio 2024 * |
16.2
x | P/E ratio 2025 * |
15.4
x | Employees | 131,900 |
Yield 2024 * |
3.3% | Yield 2025 * |
3.45% | Free-Float | 77.1% |
Latest transcript on Johnson & Johnson
1 day | +0.19% | ||
1 week | -1.86% | ||
Current month | -7.49% | ||
1 month | -7.25% | ||
3 months | -8.17% | ||
6 months | -0.47% | ||
Current year | -6.64% |
Managers | Title | Age | Since |
---|---|---|---|
Joaquin Duato
CEO | Chief Executive Officer | 61 | 88-12-31 |
Joseph Wolk
DFI | Director of Finance/CFO | 57 | 97-12-31 |
James Swanson
CTO | Chief Tech/Sci/R&D Officer | 58 | 19-11-04 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marillyn Hewson
BRD | Director/Board Member | 70 | 19-04-24 |
D. Davis
BRD | Director/Board Member | 72 | 14-06-18 |
Anne Mulcahy
BRD | Director/Board Member | 70 | 09-10-21 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
14.01% | 215 M€ | +10.50% | - | |
12.91% | 18 M€ | +3.79% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-29 | 146.4 | +0.17% | 4 221 237 |
24-04-26 | 146.1 | -0.46% | 6,182,982 |
24-04-25 | 146.8 | -1.15% | 7,642,732 |
24-04-24 | 148.5 | -0.69% | 9,756,259 |
24-04-23 | 149.6 | +0.30% | 10,110,442 |
Delayed Quote Nyse, April 29, 2024 at 12:39 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.64% | 352B | |
+25.61% | 661B | |
+26.74% | 566B | |
+19.42% | 332B | |
+3.49% | 283B | |
+13.43% | 231B | |
+4.71% | 200B | |
-9.53% | 195B | |
-4.75% | 145B | |
-10.69% | 144B |
- Stock Market
- Equities
- JNJ Stock